Related Experiment Video
Updated: Oct 14, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac Rehabilitation in Patients With Ventricular Assist Device.
Tabea Amstad1, Jan Taeymans, Lars Englberger
1Zürcher RehaZentren Klinik Wald, Zürich, Switzerland (Ms Amstad and Dr Hermann); Section of Physiotherapy, Department of Health Professions, Bern University of Applied Sciences, Berne, Switzerland (Ms Amstad and Dr Taeymans); University Hospital Berne (Inselspital), Bern, Switzerland (Drs Englberger and Mohacsi); Berner Reha Zentrum, Heiligenschwendi, Switzerland (Mr Steiner); and University Heart Center Zürich, UniversityHospital Zurich, Zürich, Switzerland (Drs Wilhelm and Hermann).
Cardiac rehabilitation significantly improves exercise capacity and quality of life for ventricular assist device patients. Destination therapy patients and those with left VADs showed greater benefits during recovery.
Area of Science:
- Cardiology
- Rehabilitation Medicine
- Medical Devices
Background:
- Ventricular assist devices (VADs) are crucial for end-stage heart failure management.
- Cardiac rehabilitation (CR) is vital for optimizing patient outcomes post-VAD implantation.
- Assessing exercise capacity (EC) and quality of life (QoL) is essential for VAD recipients.
Purpose of the Study:
- To evaluate the impact of cardiac rehabilitation on exercise capacity and quality of life in patients with VADs.
- To identify specific patient subgroups that experience differential benefits from CR.
Main Methods:
- Retrospective analysis of 110 VAD patients undergoing CR between 2007 and 2017.
- Assessment of 6-minute walk test (6MWT), Functional Independence Measure (FIM), ergometry, MacNew Heart Disease Questionnaire (MNH), and Hospital Anxiety and Depression Scale (HADS).
- Comparison of outcomes at entry and discharge from CR.
Main Results:
- Significant improvements were observed in 6MWT distance, ergometry, FIM scores, and MNH scores post-CR (P < .001).
- Hospital Anxiety and Depression Scale scores did not significantly improve (P = .637).
- Patients on destination therapy and those with left VADs demonstrated greater improvements in 6MWT compared to bridge-to-transplant and biventricular VAD patients, respectively.
Conclusions:
- Cardiac rehabilitation leads to statistically and clinically significant improvements in EC and QoL for VAD patients.
- Destination therapy patients and those with left VADs derive greater benefits from CR.
- Further research into psychological outcomes (HADS) may be warranted.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy VI: Nursing Management

